Clinical Trial

Echocardiography Guided TAVR (Echo TAVR)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 19, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Conventional transcatheter aortic valve replacement (TAVR) relies on fluoroscopic and contrast agents. However, in high-risk patients, exposure to ionizing radiation and contrast agents is contraindicated and undesirable. Echocardiography guidance TAVR can offer a feasible and safer strategy for TAVR.
Trial Details
NCT Number NCT07030062
Lead Sponsor Pan Xiangbin
Conditions Transcatheter Aortic Valve Replacemen, Echocardiography
Enrollment 20 participants
Start Date 2025-02-18
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-19